SEC Form 4 · accession 0001654954-17-009224
Acer Therapeutics Inc. · ACER
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Steve Aselage
Director
Period of report
Oct 4, 2017
Accepted (ET)
Oct 6, 2017 · 4:11 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001069308
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $15.34 | Oct 4, 2017 | A | 6,000 | A | — | Oct 4, 2027 | Common Stock | 6,000 | 6,000 | D |
Explanation of responses
- F1The option vests and becomes exercisable in full on October 4, 2018.